Unlock instant, AI-driven research and patent intelligence for your innovation.

Spray for treating burns, scalds and chronic ulcer and its preparation

A chronic ulcer and spray technology, applied in aerosol delivery, medical preparations containing active ingredients, pharmaceutical formulations, etc., can solve problems such as poor stability, short half-life in vivo, and easy to produce immunogenicity

Inactive Publication Date: 2009-10-14
WENZHOU MEDICAL UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, animal experiments have confirmed that aFGF has a significant effect on the repair of certain body injuries and disease treatment, such as: aFGF can accelerate the healing of burn wounds; it can reduce the damage of acute ischemia-reperfusion to liver, kidney, heart and other internal organs; Participate in the repair of spinal cord injury; can delay and prevent further damage of cochlear hair cells in the process of sound damage; can promote the establishment of collateral circulation, but like other protein drugs, acidic fibroblast growth factor aFGF also has poor stability and in vivo Short half-life and easy to produce immunogenicity, etc., the above defects have been effectively improved by the polyethylene glycol-directed chemical modification method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] (1) Take 1 mg of acidic fibroblast growth factor polyethylene glycol chemically modified product (PEG-aFGF), 50 mg of albumin, 5 mg of ethylparaben, 0.1 mg of EDTA-2Na, add 10 mL of water for injection or normal saline, and finally It is best to dissolve in normal saline, filter and sterilize after the dissolution is complete; (2) Dissolve 1g of zedoary oil and 100mg of cinnamon syrup in 990mL of water for injection or normal saline, preferably in water for injection, and filter to sterilize; (3) Dissolve The above-mentioned PEG-aFGF solution was thoroughly mixed with the warm zedoary oil solution, sterilized by filtration, and set aside.

Embodiment 2

[0019] (1) Take acidic fibroblast growth factor polyethylene glycol chemically modified product (PEG-aFGF) 100mg, mannitol 1mg, sodium benzoate 10mg, EDTA-2Na 0.5mg, use 10mL water for injection or normal saline, preferably physiological Dissolve in saline, filter and sterilize after complete dissolution; (2) dissolve 20 mg of zedoary oil and 10 mg of xylitol in 990 mL of water for injection or normal saline, preferably in water for injection, and filter to sterilize; (3) the above PEG - The aFGF solution and the warm zedoary oil solution were thoroughly mixed, sterilized by filtration, and set aside.

Embodiment 3

[0021] (1) Take 50 mg of acidic fibroblast growth factor polyethylene glycol chemically modified product (PEG-aFGF), 30 mg of chitin polysaccharide, 1 mg of sorbitol, 1 mg of EDTA-2Na, and use 10 mL of water for injection or normal saline, preferably physiological Dissolve in saline, filter and sterilize after complete dissolution; (2) dissolve 100mg of zedoary oil and 200mg of apple essence in 990mL water for injection or normal saline, preferably in water for injection, and sterilize by filtration; (3) mix the above PEG- The aFGF solution and the warm zedoary oil solution were thoroughly mixed, sterilized by filtration, and set aside.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to a spray for treating burn and scald chronic ulcer, which uses acidic fibroblast growth factor polyethylene glycol chemically modified product PEG-aFGF as the main medicinal component and a preparation method thereof. The main components and content of the spray are: 1-100μg / mL acidic fibroblast growth factor polyethylene glycol chemically modified product (PEG-aFGF), 1-100mg / mL warm zedoary oil, 0.001-0.05mg / mL protective agent , 0.001-0.01mg / mL preservative, 0.0001-0.001mg / mL stabilizer, 0.01-0.2mg / mL flavoring agent, and the rest is normal saline or water for injection. The preparation has the characteristics of good stability, long biological half-life, good safety and the like.

Description

technical field [0001] The invention relates to a liquid or freeze-dried powder spray with additional solvent mainly used for treating burns, fresh wounds, chronic ulcers, cervical erosion and other diseases, specifically chemically modified with acidic fibroblast growth factor polyethylene glycol The product PEG-aFGF is a liquid or freeze-dried spray with additional solvent as the main pharmaceutical ingredient. Background technique [0002] Acidic fibroblast growth factor (aFGF) is the second member of the FGFs family to be isolated and purified. Thomas isolated and purified a mixture of two sizes of polypeptides (140Aa and 134Aa) from bovine brain in 1984. It is A broad-spectrum mitogen, which has 55% amino acid sequence identity with cationic polypeptide bFGF isolated from bovine pituitary gland. aFGF is mainly distributed in organs or tissues such as brain, pituitary gland, nerve tissue, retina, adrenal gland, heart and bone, and the content of other tissues is very sm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/19A61K36/906A61K9/12A61P17/02
Inventor 李校堃黄志锋肖健倪春燕张翼
Owner WENZHOU MEDICAL UNIV